Jeb Keiper, CEO of Nimbus Therapeutics, on computational drug discovery, an unusual business model, and an important new Tyk2 inhibitor for psoriasis and other forms of autoimmunity.

Ep127: Jeb Keiper on Computational Drug Discovery

"The Long Run"

Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. 

Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

Science

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

Share Ep127: Jeb Keiper on Computational Drug Discovery

Sign up to save your podcasts

Ep127: Jeb Keiper on Computational Drug Discovery

Ep127: Jeb Keiper on Computational Drug Discovery

More shows like The Long Run with Luke Timmerman

Freakonomics Radio

POP | TECH | JAM

Making Sense with Sam Harris

a16z Podcast

About Men Radio

The Bio Report

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch

Odd Lots

Strings and Things

Founders

The Workup

The Readout Loud

The Journal.

Biotech 2050 Podcast

Business Of Biotech

BioCentury This Week

Hard Fork

Raising Health

Business Breakdowns